Iain A. McNeish
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment 86
- Oncology top 0.5%
- PARP inhibition in cancer therapy 48
- CAR-T cell therapy research 22
- Immunology top 1%
- Biotechnology top 0.5%
- Cancer Research and Treatments 19
- Cancer Research top 2%
-
- Virus-based gene therapy research 47
-
- CRISPR and Genetic Engineering 21
-
- Renal cell carcinoma treatment 15
-
- Intraperitoneal and Appendiceal Malignancies 15
- Co-authors
- Nicholas R. LemoineFrances R. BalkwillHagen KulbeSally P. WheatleyKellie A. CharlesToby LawrenceStephen C. RobinsonRichard G. Thompson
- Journals
- Journal of Clinical Investigation (1 paper)The Journal of Experimental Medicine (1 paper)Journal of Clinical Oncology (28 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Iain A. McNeish
188 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Reproductive Medicine 1.3k
- Oncology 2.9k
- Immunology 1.6k
- Biotechnology 605
- Cancer Research 940
Countries citing papers authored by Iain A. McNeish
This map shows the geographic impact of Iain A. McNeish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iain A. McNeish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iain A. McNeish more than expected).
Fields of papers citing papers by Iain A. McNeish
This network shows the impact of papers produced by Iain A. McNeish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iain A. McNeish. The network helps show where Iain A. McNeish may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Iain A. McNeish, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 19 | |
| 3 | 2023 | 13 | |
| 4 | 2022 | 1 | |
| 5 | 2021 | 1 | |
| 6 | 2020 | 147 | |
| 7 | 2019 | 16 | |
| 8 | 2017 | 29 | |
| 9 | 2016 | 150 | |
| 10 | 2016 | 111 | |
| 11 | 2015 | 16 | |
| 12 | 2015 | 12 | |
| 13 | 2014 | 36 | |
| 14 | 2012 | 26 | |
| 15 | 2011 | 164 | |
| 16 | 2011 | 313 | |
| 17 | 2011 | 49 | |
| 18 | 2010 | 216 | |
| 19 | 2008 | 36 | |
| 20 | 2006 | 23 |
About Iain A. McNeish
Iain A. McNeish is a scholar working on Reproductive Medicine, Oncology and Biotechnology, having authored 199 papers that have together received 6.9k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (86 papers), PARP inhibition in cancer therapy (48 papers), Virus-based gene therapy research (47 papers), CAR-T cell therapy research (22 papers), CRISPR and Genetic Engineering (21 papers), Cancer Research and Treatments (19 papers), Renal cell carcinoma treatment (15 papers) and Intraperitoneal and Appendiceal Malignancies (15 papers). The work is most often cited by research in Reproductive Medicine (1.3k citations), Oncology (2.9k citations) and Immunology (1.6k citations). Iain A. McNeish has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Nicholas R. Lemoine, Frances R. Balkwill, Hagen Kulbe, Sally P. Wheatley, Kellie A. Charles, Toby Lawrence, Stephen C. Robinson, Richard G. Thompson, Thorsten Hagemann and Gordon Rustin. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.